Harpoon Therapeutics, Inc. announced that Julie Eastland has been named Chief Executive Officer, effective November 8, 2021. Ms. Eastland will succeed Jerry McMahon, Ph.D., who has resigned from his position as Chief Executive Officer. Dr. McMahon has entered into a retirement and transition agreement with Harpoon and will serve as an advisor. Julie Eastland joined the Harpoon Board in 2018 and her career spans more than 20 years of executive leadership in the biotechnology industry. Most recently she served as Chief Operating Officer and Chief Financial Officer of ReCode Therapeutics.